Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q4 2017 call → NOWe need to determine if the transcript describes a situation where the company is currently in the middle of copying a proven part of its business into additional places with visible demand. The key is: a proven instance, copies being stood up now, and demand already identified at the destination. Let's scan the transcript for such a description. The most likely candidate is OptumCare's expansion into new markets, particularly with the DaVita Medical Group acquisition. But that is an acquisition, not a copy of an existing proven instance. However, there is also mention of expanding primary care practices into new metropolitan areas. Let's look for specific language. Larry Renfro says: "We expanded OptumCare primary care driven practices into 10 new major metropolitan areas. This includes our pending acquisition of DaVita Medical Group, with more than 2000 employed or affiliated physicians serving 2 million patients annually." That is an acquisition, not a replication of an existing proven model. But also earlier: "We plan to accelerate center development in 2018 and 2019." That is about surgical care affiliates. But is that a proven instance? They mention same-store growth of 7% for Surgical Care Affiliates. That is a proven instance. And they plan to accelerate center development. But is that "currently in the middle of copying"? They say "We plan to accelerate center development in 2018 and 2019." That is future, not currently being stood up. Also, demand? Not clearly identified. Another possibility: The expansion of OptumCare into new markets. They mention "we are in 35 local care delivery markets, nearly one-half of the 75 markets targeted for engagement or development." That suggests they are in the process of building out. But is there a proven instance? They have existing OptumCare practices that work. And they are adding new ones. But the demand? They mention "we are still in the early stages of growth and development, a fraction of the size they are targeted ultimately." That suggests they are building out, but is there demand already visible? They don't explicitly say that there are waiting patients or committed contracts. They talk about the potential. Another possibility: The expansion of the Nexus ACO product. Steve Nelson says: "We expanded into several new markets including the western slope of Colorado and upstate New York.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.